There were 922 press releases posted in the last 24 hours and 358,265 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Application for AVT06, a Proposed Biosimilar to Eylea® (aflibercept)

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image